Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes
Claire L Meek1,2, Zoe A Stewart3, Denice S Feig4,5,6
1Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. clm70@cam.ac.uk.
Insights
Maternal hyperglycemia in type 1 diabetes pregnancy alters lipid metabolism, impacting offspring health. Early interventions targeting maternal diet and insulin are crucial for better pregnancy outcomes.
Area of Science:
- Metabolomics
- Endocrinology
- Obstetrics
Background:
- Type 1 diabetes in pregnancy presents risks like maternal hyperglycemia and offspring hyperinsulinism.
- Perinatal complications such as pre-eclampsia and large for gestational age (LGA) are associated with suboptimal pregnancy outcomes.
- Understanding metabolomic patterns can identify risks and complications in type 1 diabetes pregnancies.
Purpose of the Study:
- To assess metabolomic patterns linked to risk factors and perinatal complications in type 1 diabetes pregnancies.
- To investigate associations between maternal hyperglycemia, diet, BMI, weight gain, and specific metabolite profiles.
- To correlate metabolomic profiles with adverse perinatal outcomes including pre-eclampsia, LGA, neonatal hypoglycemia, and hyperinsulinism.
Main Methods:
- Utilized serum samples from 174 participants in the Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial (CONCEPTT).
- Performed untargeted metabolite analysis using ultrahigh performance liquid chromatography-mass spectrometry (LC-MS).
- Applied adjusted logistic/linear regression to analyze maternal and cord blood metabolites against risk factors and complications.
Main Results:
- Maternal time-above-range in glucose monitoring correlated with increased maternal triacylglycerols and cord blood carnitines.
- Distinct metabolomic profiles were observed for LGA, neonatal hypoglycemia, and offspring hyperinsulinism, with LGA linked to carnitines and steroid hormones.
- Neonatal hypoglycemia and hyperinsulinism showed early metabolic changes (first trimester) involving triacylglycerols and dietary phenols; pre-eclampsia was associated with phosphatidylethanolamines.
Conclusions:
- Altered lipid metabolism is a central pathophysiological aspect of type 1 diabetes during pregnancy.
- Metabolomic analysis reveals distinct profiles associated with specific pregnancy complications.
- Optimizing maternal diet and insulin therapy from the first trimester is essential for improving pregnancy outcomes in type 1 diabetes.
Aims/Hypothesis:
Type 1 diabetes in pregnancy is associated with suboptimal pregnancy outcomes, attributed to maternal hyperglycaemia and offspring hyperinsulinism (quantifiable by cord blood C-peptide). We assessed metabolomic patterns associated with risk factors (maternal hyperglycaemia, diet, BMI, weight gain) and perinatal complications (pre-eclampsia, large for gestational age [LGA], neonatal hypoglycaemia, hyperinsulinism) in the Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial (CONCEPTT).
Methods:
A total of 174 CONCEPTT participants gave ≥1 non-fasting serum sample for the biorepository at 12 gestational weeks (147 women), 24 weeks (167 women) and 34 weeks (160 women) with cord blood from 93 infants. Results from untargeted metabolite analysis (ultrahigh performance LC-MS) are presented as adjusted logistic/linear regression of maternal and cord blood metabolites, risk factors and perinatal complications using a modified Bonferroni limit of significance for dependent variables.
Results:
Maternal continuous glucose monitoring time-above-range (but not BMI or excessive gestational weight gain) was associated with increased triacylglycerols in maternal blood and increased carnitines in cord blood. LGA, adiposity, neonatal hypoglycaemia and offspring hyperinsulinism showed distinct metabolite profiles. LGA was associated with increased carnitines, steroid hormones and lipid metabolites, predominantly in the third trimester. However, neonatal hypoglycaemia and offspring hyperinsulinism were both associated with metabolite changes from the first trimester, featuring triacylglycerols or dietary phenols. Pre-eclampsia was associated with increased abundance of phosphatidylethanolamines, a membrane phospholipid, at 24 weeks.
Conclusions/Interpretation:
Altered lipid metabolism is a key pathophysiological feature of type 1 diabetes pregnancy. New strategies for optimising maternal diet and insulin dosing from the first trimester are needed to improve pregnancy outcomes in type 1 diabetes.
More Related Videos
10:34Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...